Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 82742 refers to a laboratory test specifically designed to measure the concentration of Flurazepam in the bloodstream. Flurazepam is a medication classified as a benzodiazepine, which is commonly prescribed under the brand name Dalmane. This medication is primarily utilized for the treatment of insomnia, as it effectively lowers brain activity, facilitating the onset of sleep. In addition to its sedative properties, Flurazepam is also beneficial in managing anxiety, relaxing skeletal muscles, and reducing seizure activity. One notable characteristic of Flurazepam is its long half-life, which allows it to remain detectable in the bloodstream for up to four days following ingestion. This extended duration of action makes Flurazepam particularly useful when administered the night before a medical or dental procedure, as it not only promotes sleep but also helps to alleviate anxiety that may be experienced the following day. The testing process for Flurazepam involves obtaining a blood sample through a procedure known as venipuncture, which is reported separately. The analysis of the serum or plasma is conducted using a sophisticated technique called quantitative liquid chromatography-tandem mass spectrometry, ensuring accurate measurement of the drug's levels in the patient's system.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test for Flurazepam is indicated for several specific conditions and circumstances, primarily related to its use as a medication. The following are the explicit indications for performing this test:
The procedure for testing Flurazepam involves several key steps that ensure accurate measurement of the drug's concentration in the bloodstream. The following procedural steps are explicitly outlined:
After the procedure, there are several considerations for both the patient and healthcare providers. The patient may experience minor discomfort at the venipuncture site, which typically resolves quickly. It is important to monitor the patient for any adverse reactions, especially if they are on Flurazepam or other medications that may affect their response. The results of the Flurazepam test will be communicated to the prescribing physician, who will use this information to assess the effectiveness of the treatment plan. Depending on the results, the physician may decide to adjust the dosage of Flurazepam or explore alternative treatment options. Additionally, patients should be advised to follow up with their healthcare provider to discuss the results and any necessary changes to their medication regimen.
| Short Descr | ASSAY OF FLURAZEPAM | Medium Descr | ASSAY OF FLURAZEPAM | Long Descr | Flurazepam | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
Get instant expert-level medical coding assistance.